Study of VKORC1, CYP2C9, and CYP4F2 polymorphisms and their association with warfarin dose requirements in Egyptian patients.

被引：0
|
作者：
Shahin, Mohamed H. [1 ]
Khalifa, Sherief I. [2 ]
Sallam, Tarif H. [3 ]
Hammad, Lamiaa N. [1 ]
El Shafey, Mostafa [4 ]
Ali, Shawky S. [4 ]
Mohamed, Mohamed-Eslam F. [5 ]
Langaee, Taimour [5 ]
Johnson, Julie A. [5 ]
机构：
[1] Misr Int Univ, Cairo, Egypt
[2] Qatar Univ, Doha, Qatar
[3] Ain Shams Univ, Cairo, Egypt
[4] Al Azhar Univ, Cairo, Egypt
[5] Univ Florida, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
39
引用
收藏
页码：1065 / 1065
页数：1
相关论文
共 50 条
  • [1] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    BLOOD, 2012, 120 (21)
  • [2] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Taisei Mushiroda
    Yozo Ohnishi
    Susumu Saito
    Atsushi Takahashi
    Yuka Kikuchi
    Shigeru Saito
    Hideki Shimomura
    Yasuhiko Wanibuchi
    Takao Suzuki
    Naoyuki Kamatani
    Yusuke Nakamura
    Journal of Human Genetics, 2006, 51 : 249 - 253
  • [3] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Mushiroda, T
    Ohnishi, Y
    Saito, S
    Takahashi, A
    Kikuchi, Y
    Saito, S
    Shimomura, H
    Wanibuchi, Y
    Suzuki, T
    Kamatani, N
    Nakamura, Y
    JOURNAL OF HUMAN GENETICS, 2006, 51 (03) : 249 - 253
  • [4] The effect of polymorphisms in CYP2C9, CYP4F2, EPHX1 and VKORC1 on warfarin dose in Turkish patients
    Ozer, Mahmut
    Demirci, Yeliz
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Hizel, Candan
    Alpan, Serdar
    Genc, Ece
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S125 - S125
  • [5] Impact of VKORC1, CYP2C9, and CYP4F2 Polymorphisms on Optimal Warfarin Dose: Does Ethnicity Matters?
    Li, Jia X.
    Kim, Moo H.
    Song, Kai
    Guo, Long Z.
    Jin, En Z.
    Kim, Soo J.
    Lee, Kwang M.
    Serebruany, Victor
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E461 - E468
  • [6] Erratum to: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Takuya Wakamiya
    Tatsunori Hokosaki
    Shin-ichi Tsujimoto
    Keisuke Kadota
    Yusuke Nakano
    Shigeo Watanabe
    Mari Iwamoto
    Masakatsu Yanagimachi
    Shuichi Ito
    Molecular Diagnosis & Therapy, 2016, 20 : 501 - 501
  • [7] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    G. Oner Ozgon
    T. Y. Langaee
    H. Feng
    N. Buyru
    T. Ulutin
    A. C. Hatemi
    A. Siva
    S. Saip
    J. A. Johnson
    European Journal of Clinical Pharmacology, 2008, 64 : 889 - 894
  • [8] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    Ozgon, G. Oner
    Langaee, T. Y.
    Feng, H.
    Buyru, N.
    Ulutin, T.
    Hatemi, A. C.
    Siva, A.
    Saip, S.
    Johnson, J. A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (09) : 889 - 894
  • [9] Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
    Sridharan, Kannan
    Al Banna, Rashed
    Malalla, Zainab
    Husain, Aysha
    Sater, Mai
    Jassim, Ghufran
    Otoom, Sameer
    PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1405 - 1417
  • [10] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes
    Teichert, Martina
    Eijgelsheim, Mark
    Uitterlinden, Andre G.
    Buhre, Peter N.
    Hofman, Albert
    De Smet, Peter A. G. M.
    Visser, Loes E.
    Stricker, Bruno H. Ch.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 26 - 34
12345